Company Filing History:
2 out of 3,685 
1 out of 152 
1 out of 389 
Years Active: 2000-2006
Title: Mark D Lindrud: Innovator in Pharmaceutical Chemistry
Introduction
Mark D Lindrud is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of irbesartan, a medication used to treat cardiovascular diseases. With a total of 4 patents to his name, Lindrud's work has had a meaningful impact on the pharmaceutical industry.
Latest Patents
Lindrud's latest patents focus on novel crystalline forms of irbesartan. One of his inventions relates to a crystalline form of irbesartan, processes for obtaining it, and pharmaceutical compositions containing it. This invention is crucial for treating cardiovascular diseases. Another patent also addresses a novel crystalline form of irbesartan, along with methods for obtaining this form and pharmaceutical compositions that include it. These innovations highlight his dedication to improving therapeutic options for patients.
Career Highlights
Throughout his career, Mark D Lindrud has worked with prominent companies in the pharmaceutical sector. He has been associated with Bristol-Myers Squibb Company and Sanofi-Synthelabo, where he contributed to various projects that advanced drug development and formulation.
Collaborations
Lindrud has collaborated with several professionals in his field, including Chenkou Wei and Bruno Franc. These partnerships have likely enriched his research and contributed to the success of his inventions.
Conclusion
Mark D Lindrud's contributions to pharmaceutical chemistry, particularly in the development of irbesartan, demonstrate his innovative spirit and commitment to improving healthcare. His work continues to influence the industry and offers hope for better treatment options for cardiovascular diseases.